Well, specifically, Goldman Sachs. This is the same organization or BAILOUT BANK, that got preferential treatment by getting the H1N1 vaccine (or swine flu) before millions of AT RISK AMERICANS.
I mean, how low down is that? And Washington, DC does not understand the angst out here, especially on Main Street?
So, why are we surprised that Wall Street, of all places, do not want any health care reform. It is not in their best interest, monetarily.
A Goldman Sachs analysis of health care legislation has concluded that, as far as the bottom line for insurance companies is concerned, the best thing to do is nothing. A close second would be passing a watered-down version of the Senate Finance Committee's bill.
A study put together by Goldman in mid-October looks at the estimated stock performance of the private insurance industry under four variations of reform legislation. The study focused on the five biggest insurers whose shares are traded on Wall Street: Aetna, UnitedHealth, WellPoint, CIGNA and Humana.
The Senate Finance Committee bill, which Goldman's analysts conclude is the version most likely to survive the legislative process, is described as the "base" scenario. Under that legislation (which did not include a public plan) the earnings per share for the top five insurers would grow an estimated five percent from 2010 through 2019. And yet, the "variance with current valuation" -- essentially, what the value of the stock is on the market -- is projected to drop four percent. read more here...
If the Democrats screw health care reform and give us a watered down bill to say, "Reform", they are in a lot of trouble this time next year.
Home Page
Share
